BR0013765A - 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-ona substituìda e seu emprego como inibidor de lipase - Google Patents

3-fenil-5-alcóxi-1,3,4-oxdiazol-2-ona substituìda e seu emprego como inibidor de lipase

Info

Publication number
BR0013765A
BR0013765A BR0013765-0A BR0013765A BR0013765A BR 0013765 A BR0013765 A BR 0013765A BR 0013765 A BR0013765 A BR 0013765A BR 0013765 A BR0013765 A BR 0013765A
Authority
BR
Brazil
Prior art keywords
alkyl
cycloalkyl
oxdiazol
phenyl
substituted
Prior art date
Application number
BR0013765-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Stefan Petry
Kart Schoenafinger
Guenter Mueller
Karl-Heinz Baringhaus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0013765A publication Critical patent/BR0013765A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR0013765-0A 1999-09-04 2000-08-22 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-ona substituìda e seu emprego como inibidor de lipase BR0013765A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (1)

Publication Number Publication Date
BR0013765A true BR0013765A (pt) 2002-04-30

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013765-0A BR0013765A (pt) 1999-09-04 2000-08-22 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-ona substituìda e seu emprego como inibidor de lipase

Country Status (30)

Country Link
US (1) US6596742B1 (enExample)
EP (1) EP1214302B1 (enExample)
JP (1) JP2003508522A (enExample)
KR (1) KR100723817B1 (enExample)
CN (1) CN1152024C (enExample)
AR (1) AR032430A1 (enExample)
AT (1) ATE253059T1 (enExample)
AU (1) AU781330B2 (enExample)
BR (1) BR0013765A (enExample)
CA (1) CA2383731A1 (enExample)
CZ (1) CZ2002772A3 (enExample)
DE (2) DE19942354A1 (enExample)
DK (1) DK1214302T3 (enExample)
EE (1) EE04811B1 (enExample)
ES (1) ES2204685T3 (enExample)
HK (1) HK1048318B (enExample)
HR (1) HRP20020187A2 (enExample)
HU (1) HUP0202988A3 (enExample)
IL (2) IL148275A0 (enExample)
MX (1) MXPA02001834A (enExample)
NO (1) NO323129B1 (enExample)
NZ (1) NZ517551A (enExample)
PL (1) PL197314B1 (enExample)
PT (1) PT1214302E (enExample)
RU (1) RU2265600C2 (enExample)
SK (1) SK285924B6 (enExample)
TR (1) TR200200553T2 (enExample)
WO (1) WO2001017981A1 (enExample)
YU (1) YU10402A (enExample)
ZA (1) ZA200201594B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
US7799915B2 (en) * 2004-10-13 2010-09-21 Wyeth Llc Anilino-pyrimidine analogs
WO2009009287A2 (en) * 2007-07-12 2009-01-15 Deviris Inc. Hormone sensitive lipase modulators and methods of use
BRPI0821482A2 (pt) * 2007-12-27 2015-07-14 Bial Portela & Ca Sa 3-n-fenil-1,3,4-oxadiazolona 5-o-substituída, seu uso, sua composição e seu processo de preparação
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
EP0067471B1 (en) 1981-06-15 1985-11-06 Shell Internationale Researchmaatschappij B.V. 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
SK285924B6 (sk) 2007-11-02
YU10402A (sh) 2004-11-25
DE50004274D1 (de) 2003-12-04
PT1214302E (pt) 2004-03-31
EP1214302B1 (de) 2003-10-29
HK1048318A1 (en) 2003-03-28
JP2003508522A (ja) 2003-03-04
AR032430A1 (es) 2003-11-12
IL148275A0 (en) 2002-09-12
PL353214A1 (en) 2003-11-03
EE200200109A (et) 2003-06-16
ES2204685T3 (es) 2004-05-01
ATE253059T1 (de) 2003-11-15
EE04811B1 (et) 2007-04-16
NZ517551A (en) 2003-10-31
NO323129B1 (no) 2007-01-08
HUP0202988A3 (en) 2004-12-28
KR100723817B1 (ko) 2007-06-04
HUP0202988A2 (hu) 2002-12-28
TR200200553T2 (tr) 2002-06-21
HRP20020187A2 (en) 2004-02-29
IL148275A (en) 2008-08-07
NO20021007D0 (no) 2002-02-28
NO20021007L (no) 2002-02-28
CN1152024C (zh) 2004-06-02
MXPA02001834A (es) 2002-08-12
DE19942354A1 (de) 2001-03-08
AU781330B2 (en) 2005-05-19
EP1214302A1 (de) 2002-06-19
WO2001017981A1 (de) 2001-03-15
DK1214302T3 (da) 2004-02-16
HK1048318B (zh) 2004-12-10
RU2265600C2 (ru) 2005-12-10
CZ2002772A3 (cs) 2002-05-15
PL197314B1 (pl) 2008-03-31
SK3012002A3 (en) 2002-06-04
CN1371369A (zh) 2002-09-25
KR20020024336A (ko) 2002-03-29
CA2383731A1 (en) 2001-03-15
AU7411200A (en) 2001-04-10
US6596742B1 (en) 2003-07-22
ZA200201594B (en) 2003-04-30

Similar Documents

Publication Publication Date Title
BR9813508A (pt) Inibição de replicação viral associada com membrana
AU2733997A (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
BR9707010A (pt) Derivados de aminoácidos sulfonados e inibidores de metalproteinase contendo os mesmos
BR9905751A (pt) Compostos de dipeptìdeo, uso e processo para preparação dos mesmos, composições fungicidas, e, processos para a preparação das mesmas, e, para combater infecções por fungos
PT1058683E (pt) Inibidores da farnesil-transferase com uma estrutura de piperidina e seu processo de preparacao
TR199902606T2 (xx) Farnesil transferaz� engelleyici kinazolinonlar.
DK0892780T3 (da) m-Amidinophenylanaloger som faktor Xa-inhibitorer
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
DK0696280T3 (da) Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
BR0306957A (pt) Herbicidas
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BR0210531A (pt) Derivados de ácido sulfÈnico
DK0744397T3 (da) Fluorphenylsubstituerede alkenylcarboxylsyre-guanidiner som Na+/K+-antiport-inhibitorer, deres anvendelse som lægemiddel el
BRPI0302496C1 (pt) composições farmacêuticas com atividade antibiótica
BR9907746A (pt) ácidos 2,3,4,5-tetraidro-1h[1,4]-benzodiazepina-3-hidroxâmic os como inibidores de matriz de metaloproteinase
DE69709933D1 (en) Aromatische amidinderivate als selektive thrombininhibitoren
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
BR0013582A (pt) Agonistas retinóides seletivos para rar
BR9814188A (pt) "agonistas de 5-ht1f"
ES2182090T3 (es) Nuevos derivados de pirrol.
NO992731D0 (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07D 271/113, C07D 413/12, C07D 31/4245; A61P 3/10

Ipc: C07D 271/113 (2009.01), C07D 271/10 (2009.01), C07

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements